Claus Moser
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities
Papers in
-
- Antibiotic Resistance in Bacteria 20
- Microbiology 19
- Co-authors
- Niels HøibyPeter Østrup JensenThomas BjarnsholtMichael GivskovOana CiofuZhijun SongHong WuHelle Krogh Johansen
- Journals
- Apmis (27 papers)Journal of Cystic Fibrosis (9 papers)Clinical & Experimental Immunology (6 papers)Journal of Antimicrobial Chemotherapy (6 papers)Journal of Clinical Microbiology (6 papers)
- Partner nations
- DenmarkUnited StatesAustralia
In The Last Decade
Claus Moser
206 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Molecular Medicine 1.6k
- Microbiology 1.7k
- Endocrinology 1.2k
- Periodontics 987
- Rehabilitation 969
Countries citing papers authored by Claus Moser
This map shows the geographic impact of Claus Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Moser more than expected).
Fields of papers citing papers by Claus Moser
This network shows the impact of papers produced by Claus Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Moser. The network helps show where Claus Moser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claus Moser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 8 | |
| 11 | Tolerance and resistance of microbial biofilms Hit paper breakdown → | 2022 | 667 |
| 12 | 2021 | 8 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 22 | |
| 16 | 2018 | 15 | |
| 17 | 2017 | 15 | |
| 18 | 2013 | 66 | |
| 19 | 2012 | 268 | |
| 20 | 1999 | 56 |
About Claus Moser
Claus Moser is a scholar working on Molecular Medicine, Microbiology, Endocrinology, Clinical Biochemistry and Rehabilitation, having authored 215 papers that have together received 11.7k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (58 papers), Infective Endocarditis Diagnosis and Management (42 papers), Cystic Fibrosis Research Advances (32 papers), Antimicrobial Resistance in Staphylococcus (25 papers), Streptococcal Infections and Treatments (22 papers), Antibiotic Resistance in Bacteria (20 papers), Wound Healing and Treatments (19 papers) and Bacterial Identification and Susceptibility Testing (19 papers). The work is most often cited by research in Molecular Medicine (1.6k citations), Microbiology (1.7k citations), Endocrinology (1.2k citations), Periodontics (987 citations) and Rehabilitation (969 citations). Claus Moser has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Niels Høiby, Peter Østrup Jensen, Thomas Bjarnsholt, Michael Givskov, Oana Ciofu, Zhijun Song, Hong Wu, Helle Krogh Johansen, Tim Tolker‐Nielsen and Morten Alhede. Their work appears in journals such as Apmis, Journal of Cystic Fibrosis, Clinical & Experimental Immunology, Journal of Antimicrobial Chemotherapy and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.